The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world outcomes of doxorubicin plus trabectedin (D+T) in leiomyosarcoma (LMS).
 
Stephanie Soewito
No Relationships to Disclose
 
Nassar El Assaad
No Relationships to Disclose
 
Michael Nakazawa
Consulting or Advisory Role - IBF; SyzOnc
Research Funding - Exelixis; Summit Therapeutics
 
Carlos Torrado
Stock and Other Ownership Interests - Pfizer; Summit Therapeutics
 
Ryan Denu
No Relationships to Disclose
 
J. Livingston
Consulting or Advisory Role - Ipsen
Research Funding - Exelixis (Inst); Genentech/Roche (Inst)
Travel, Accommodations, Expenses - Ipsen
Other Relationship - Guidepoint Global
 
Ravin Ratan
Stock and Other Ownership Interests - Johnson & Johnson/Janssen (I); Medtronic (I)
Honoraria - Peerview; touchIME
Consulting or Advisory Role - InhibRx; SpringWorks Therapeutics
Research Funding - Ayala Pharmaceuticals (Inst); C4 Therapeutics (Inst); SpringWorks Therapeutics (Inst); SpringWorks Therapeutics (Inst)
Travel, Accommodations, Expenses - SpringWorks Therapeutics; SpringWorks Therapeutics
 
Maria Zarzour
Consulting or Advisory Role - Deciphera
Travel, Accommodations, Expenses - Deciphera
 
Anthony Conley
Consulting or Advisory Role - AADi; Applied Clinical Intelligence; Bayer; Deciphera; Deciphera; Genentech; Guidepoint Global; Guidepoint Global; Guidepoint Global; InhibRx; Medscape; Nektar; Novartis; OncLive; Schlesinger Associates
Research Funding - Bavarian Nordic (Inst); Chordoma Foundation (Inst); EpicentRx (Inst); Ignyta (Inst); InhibRx (Inst); Iovance Biotherapeutics (Inst); Krystal Biotech; Lilly (Inst); MedImmune (Inst); NantHealth (Inst); NCI (Inst); SERVIER
Travel, Accommodations, Expenses - Genentech
 
Dejka Araujo
Research Funding - Adaptimmune (Inst); GlaxoSmithKline (Inst); Immatics (Inst)
 
Shreyaskumar Patel
Consulting or Advisory Role - Daiichi Sankyo; Deciphera; Kura Oncology; Thermosome
Research Funding - Ascendo (Inst); Kura Oncology (Inst)
 
Vinod Ravi
Stock and Other Ownership Interests - AstraZeneca; Merck; Moderna Therapeutics; Pfizer; TRACON Pharma
Honoraria - UpToDate
Consulting or Advisory Role - AADi; Daiichi Sankyo; Daiichi Sankyo; Deciphera; Deciphera; EMD Serono; Gerson Lehrman Group; Guidepoint Inc
Research Funding - AADi (Inst); Athenex (Inst); Deciphera (Inst); Ikena Oncology (Inst); Ikena Oncology (Inst); Novartis (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Author Royalties from Uptodate
Travel, Accommodations, Expenses - Daiichi Sankyo; EMD Serono/Merck
 
Robert Benjamin
Stock and Other Ownership Interests - Gilead Sciences (I); Johnson & Johnson (I)
 
Larissa Meyer
Employment - Gulf Coast Vascular Partners (I)
Stock and Other Ownership Interests - Bristol-Myers Squibb; crispr therapeutics; Denali Therapeutics; InVitae; Johnson & Johnson
Consulting or Advisory Role - Abbvie; Gore & Associates (I); Venostent (I)
Research Funding - AstraZeneca; Merck
Travel, Accommodations, Expenses - Abbvie; AstraZeneca
 
Pamela Soliman
Consulting or Advisory Role - BIOPHARM; Curio Science; Eisai; GlaxoSmithKline; Medscape
Research Funding - Eisai (Inst); Leap Therapeutics (Inst); Merck (Inst); Novartis (Inst)
 
Alexander Lazar
Leadership - Archer; Iterion Therapeutics; Modella; Nucleai
Stock and Other Ownership Interests - Archer; Beta Cat Pharmaceuticals; PAIGE.AI
Honoraria - Bristol-Myers Squibb; Genentech/Roche; Janssen Oncology; Novartis
Consulting or Advisory Role - Abbvie; Bayer; BMS; Deciphera; Moderna/Merck Collaboration; Novartis
Research Funding - AstraZeneca; MedImmune; Novartis; Roche
Patents, Royalties, Other Intellectual Property - Elsevier
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
 
Emily Keung
No Relationships to Disclose
 
Christina Roland
Honoraria - i3 Health; SpringWorks Therapeutics
 
Neeta Somaiah
Stock and Other Ownership Interests - JNJ (I); Pfizer (I)
Consulting or Advisory Role - Alexion Pharmaceuticals; Bayer; Boehringer Ingelheim; Deciphera; Ipsen; Replimune
Research Funding - Advenc (Inst); Ascentage Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Cogent Biosciences (Inst); Daiichi Sankyo/Lilly (Inst); Deciphera (Inst); GlaxoSmithKline (Inst); IDRx (Inst); Karyopharm Therapeutics (Inst)
 
Elise Nassif Haddad
Honoraria - Elsevier; Sonata Therapeutics
Consulting or Advisory Role - SpringWorks Therapeutics
Research Funding - AADi (Inst); Recursion Pharmaceuticals (Inst)